Bioorganic

264 papers17 directions
Bioorganic is a research venue that has been active since 1991, with a collection of 263 papers documented through 2026. The venue focuses on the intersection of chemical biology and drug discovery, providing a platform for research into the design, synthesis, and biological evaluation of small molecules. Its scope encompasses a variety of therapeutic areas, including oncology, immunology, and antifungal treatments. Prolific contributors to the venue include researchers such as Thierry Langer, Andreas Verras, and Dong‐Ming Shen. The research published at Bioorganic frequently centers on the identification of potent inhibitors and the development of novel molecular scaffolds. Sample studies include the discovery of mTOR inhibitors for acute myeloid leukemia, URAT1 inhibitors with hypouricemic effects, and the design of PD-L1-targeted molecules for cancer therapy. The venue also features work on molecular glue degraders and natural product-inspired derivatives, reflecting a focus on diverse chemical strategies for modulating biological targets. In the context of machine learning and computational research, Bioorganic serves as a site for the application of molecular design technologies and structural analysis. The venue documents the use of emerging insights in immunomodulatory technologies and the identification of selective inhibitors, such as those targeting ROCK2 or tubulin polymerization. By publishing detailed findings on structure-activity relationships and oral bioavailability, the venue contributes to the data and methodologies used in the computational screening and optimization of therapeutic candidates.

Papers by Year

2026 1
2025 38
2024 17
2023 14
2022 22
2021 8
2020 14
2019 12
2018 7
2017 9
2016 7
2015 13
2014 10
2013 11
2012 11
2011 5
2010 13
2009 10
2008 8
2007 4
2006 4
2005 6
2004 4
2003 4
2002 4
2001 1
1998 3
1996 2
1994 1
1991 1

Top Research Directions

Research directions most represented by papers from this venue.

Stereochemical Determinants of Pharmacological Efficacy 1
Principles of Covalent Target Inhibition 1
Validating Target Specificity Through Competitive Displacement 1
Mapping Chemical Structure to Biological Activity 1
Off-Target Binding Mechanisms in Positron Emission Tomography 1
Radiolabeled Tracers for Mapping Therapeutic Macromolecule Delivery 1
Atomic Level Refinement of Predicted Molecular Geometries 1
Validating Novel Molecular Targets for Clinical Success 1
Spectroscopic Structure Elucidation of Complex Natural Products 1
Mapping Traditional Remedies to Modern Molecular Pathways 1
Deconstructing the Pharmacology of Multi Component Herbal Formulas 1
Translating Genetic Target Validation into Small Molecule Inhibitors 1
Stepwise Selection for Parsimonious Regression Modeling 1
Genome-Wide Gene Expression Profiling Using Microarrays 1
RT-qPCR Validation for Reliable Transcriptomic Analysis 1

Top Authors

AuthorPapers
Thierry Langer11
Alicia Higueruelo3
George Hripcsak3
Bowei Zhang2
Hyunwoo Kim2
Lars Olsen2
Pan Li2
Alessandro Sperduti1
Andrew Anighoro1
Chenxi Xiao1
Christian Wolfgang Feldmann1
Duo Xu1
Fei Gu1
Hui Ji1
Jing Zhang1
Shinichi Furuya1
Sichao Tian1
Wei Wei1
Xiao Ding1
Yang Liu1

Impactful Papers

Papers from this venue that shaped research clusters.

Foundational

Influential

Related Venues

Venues with the most similar research cluster distributions.

Papers

TitleYear
Conformational and SAR analysis of NAALADase and PSMA inhibitors2003
Design and synthesis of broad-Based mono- and bi- cyclic inhibitors of FIV and HIV proteases2003
CDP840. A prototype of a novel class of orally active anti-Inflammatory phosphodiesterase 4 inhibitors2002
Discovery and evaluation of N-(triazin-1,3,5-yl) phenylalanine derivatives as VLA-4 integrin antagonists2002
N-(Pyrimidin-4-yl) and N-(Pyridin-2-yl) phenylalanine derivatives as VLA-4 integrin antagonists2002
Structure–affinity relationships of the affinity of 2-pyrazolyl adenosine analogues for the adenosine A2A receptor2002
Heterocycle-based MMP Inhibitors with P2′ Substituents2001
Coumarin-based prodrugs. Part 3: Structural effects on the release kinetics of esterase-sensitive prodrugs of amines1998
Stabilization of a C7 equatorial gamma turn in DMSO-d6 by a ditryptophan crosslink1998
The retro-mannich cleavage of δ1,δ1′-tryptophan dimers1998
Chemical feasibility studies of a potential coumarin-based prodrug system1996
Molecular structure and dynamics of some potent 5-HT3 receptor antagonists. Insight into the interaction with the receptor1996
A new class of diacidic nonpeptide angiotensin II receptor antagonists1994
FKBP, thought to be identical to PKCI-2, does not inhibit protein kinase C1991

« prev Page 6/6